Literature DB >> 26851610

Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from Belgian patients.

Anne-Marie Van den Abeele1, Dirk Vogelaers2, Elke Vanlaere3, Kurt Houf4.   

Abstract

OBJECTIVES: To evaluate the feasibility of different methods for susceptibility testing of human Arcobacter isolates, to assess susceptibility to antibiotics commonly used to treat diarrhoeal illness and to obtain MIC distribution data.
METHODS: One-hundred-and-six unique Arcobacter strains were collected during an epidemiological study on pathogens in gastroenteritis. Strains were identified by multiplex PCR and PCR-RFLP, and characterized by PFGE. Susceptibility to ampicillin, erythromycin, tetracycline, doxycycline, gentamicin and ciprofloxacin was determined using gradient strip and disc diffusion methodology. Optimal conditions for growth and incubation were tested. Azithromycin was tested with gradient strip diffusion on a subset of 40 strains. Sequence analysis of the quinolone resistance-determining region of gyrA was performed for a subset of 18 strains.
RESULTS: Based on gradient diffusion results, most Arcobacter strains were susceptible to gentamicin (99%) and tetracycline (89%). Erythromycin (78%), ciprofloxacin (72%) and doxycycline (76%) retained moderate activity against Arcobacter spp. Only 9% of the strains were susceptible to ampicillin. Most Arcobacter butzleri strains were susceptible to ciprofloxacin (87%), whereas half of the Arcobacter cryaerophilus isolates (51%) showed high-level resistance (MIC >32 mg/L). MIC50 values were comparable for both macrolide antibiotics. Ciprofloxacin-resistant strains possessed an identical mutation in gyrA. Overall, categorical agreement between gradient and disc diffusion results was 60%. Gradient diffusion showed superior readability.
CONCLUSIONS: Gradient diffusion methodology is preferred for routine susceptibility testing. Acquired resistance to fluoroquinolones was observed in A. cryaerophilus. Macrolides are not first-choice empirical antibiotics for Arcobacter infections. Tetracyclines can be suggested for treatment of documented Arcobacter-related gastrointestinal infections.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26851610     DOI: 10.1093/jac/dkv483

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  Arcobacter Butzleri in an AIDS Patient.

Authors:  Trevor Hwee Yong Tan; Sai Meng Tham; Paul Anatharajah Tambyah
Journal:  Case Rep Infect Dis       Date:  2022-07-06

2.  First case of Arcobacter cryaerophilus in paediatric age in Spain.

Authors:  C Ruiz de Alegría Puig; M Macho Díaz; J Agüero Balbín; J Calvo Montes
Journal:  Rev Esp Quimioter       Date:  2021-04-03       Impact factor: 1.553

3.  Complete Genome Sequences of the Arcobacter cryaerophilus Strains ATCC 43158T and ATCC 49615.

Authors:  William G Miller; Emma Yee; James L Bono
Journal:  Microbiol Resour Announc       Date:  2018-11-21

4.  Prevalence and antimicrobial susceptibility of Arcobacter species in human stool samples derived from out- and inpatients: the prospective German Arcobacter prevalence study Arcopath.

Authors:  Greta Gölz; Markus M Heimesaat; Vanessa Brückner; Ulrike Fiebiger; Ralf Ignatius; Johannes Friesen; Martin Eisenblätter; Marlies Höck; Thomas Alter; Stefan Bereswill
Journal:  Gut Pathog       Date:  2020-04-15       Impact factor: 4.181

5.  Antimicrobial Susceptibility and Genomic Analysis of Aliarcobacter cibarius and Aliarcobacter thereius, Two Rarely Detected Aliarcobacter Species.

Authors:  Ingrid Hänel; Eva Müller; Belén González Santamarina; Herbert Tomaso; Helmut Hotzel; Anne Busch
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

6.  Characterization of AreABC, an RND-Type Efflux System Involved in Antimicrobial Resistance of Aliarcobacter butzleri.

Authors:  Susana Ferreira; Ana L Silva; Joana Tomás; Cristiana Mateus; Fernanda Domingues; Mónica Oleastro
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

7.  Characterization of the emerging zoonotic pathogen Arcobacter thereius by whole genome sequencing and comparative genomics.

Authors:  Francesca Rovetto; Aurélien Carlier; Anne-Marie Van den Abeele; Koen Illeghems; Filip Van Nieuwerburgh; Luca Cocolin; Kurt Houf
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

8.  A Polyphasic and Taxogenomic Evaluation Uncovers Arcobacter cryaerophilus as a Species Complex That Embraces Four Genomovars.

Authors:  Alba Pérez-Cataluña; Luis Collado; Oscar Salgado; Violeta Lefiñanco; María J Figueras
Journal:  Front Microbiol       Date:  2018-04-27       Impact factor: 5.640

9.  Genomic Characterization of Arcobacter butzleri Isolated From Shellfish: Novel Insight Into Antibiotic Resistance and Virulence Determinants.

Authors:  Francesca Fanelli; Angela Di Pinto; Anna Mottola; Giuseppina Mule; Daniele Chieffi; Federico Baruzzi; Giuseppina Tantillo; Vincenzina Fusco
Journal:  Front Microbiol       Date:  2019-04-16       Impact factor: 5.640

10.  Aliarcobacter butzleri from Water Poultry: Insights into Antimicrobial Resistance, Virulence and Heavy Metal Resistance.

Authors:  Eva Müller; Mostafa Y Abdel-Glil; Helmut Hotzel; Ingrid Hänel; Herbert Tomaso
Journal:  Genes (Basel)       Date:  2020-09-21       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.